公开(公告)号：US20150044691A1

公开(公告)日：2015-02-12

申请号：US14523658

申请日：2014-10-24

申请人： Shimadzu Corporation ,  Educational Corporation Mukogawa Gakuin ,  Hyogo College of Medicine

发明人： Eiichi Matsuo ,  Naoki Kaneko ,  Makoto Watanabe ,  Osamu Nishimura ,  Noboru Okamura ,  Akinobu Gotoh

IPC分类号： G01N33/574

CPC分类号： G01N33/57438 ,  C12N9/96 ,  G01N33/6893 ,  G01N2333/4724 ,  G01N2333/988

摘要： The present invention provides a blood marker for renal cancer, more specifically, a blood marker that can be practically used for clinical diagnosis of renal cancer. The present invention also provides a blood marker that can be practically used for follow-up after treatment such as surgery and during treatment such as medication for renal cancer. A blood marker for renal cancer selected from the group consisting of Galectin-1, Galectin-3, and α-enolase. Galectin-1 and/or Galectin-3 as a blood marker for renal cancer for use in an examination performed before diagnostic imaging. α-Enolase as a blood marker for renal cancer for use in monitoring during and/or after treatment for renal cancer.

摘要翻译： 本发明提供了用于肾癌的血液标志物，更具体地，可以实际用于肾癌的临床诊断的血液标志物。 本发明还提供了一种血液标志物，其可以实际用于治疗之后的后续，例如手术和治疗期间，例如用于肾癌的药物。 选自Galectin-1，Galectin-3和α-烯醇化酶的肾癌血液标志物。 Galectin-1和/或Galectin-3作为肾癌的血液标志物，用于在诊断成像之前进行的检查。 α-烯醇化酶作为用于肾癌治疗期间和/或治疗期间的肾癌的血液标志物。

公开(公告)号：US20130171660A1

公开(公告)日：2013-07-04

申请号：US13728932

申请日：2012-12-27

申请人： SHIMADZU CORPORATION ,  EDUCATIONAL CORPORATION MUKOGAWA GAKUIN ,  HYOGO COLLEGE OF MEDICINE

发明人： Eiichi Matsuo ,  Naoki Kaneko ,  Makoto Watanabe ,  Osamu Nishimura ,  Noboru Okamura ,  Akinobu Gotoh

IPC分类号： G01N33/68 ,  C12N9/96

CPC分类号： G01N33/57438 ,  C12N9/96 ,  G01N33/6893 ,  G01N2333/4724 ,  G01N2333/988

摘要： The present invention provides a blood marker for renal cancer, more specifically, a blood marker that can be practically used for clinical diagnosis of renal cancer. The present invention also provides a blood marker that can be practically used for follow-up after treatment such as surgery and during treatment such as medication for renal cancer. A blood marker for renal cancer selected from the group consisting of Galectin-1, Galectin-3, and α-enolase. Galectin-1 and/or Galectin-3 as a blood marker for renal cancer for use in an examination performed before diagnostic imaging. α-Enolase as a blood marker for renal cancer for use in monitoring during and/or after treatment for renal cancer.

摘要翻译： 本发明提供了用于肾癌的血液标志物，更具体地，可以实际用于肾癌的临床诊断的血液标志物。 本发明还提供了一种血液标志物，其可以实际用于治疗之后的后续，例如手术和治疗期间，例如用于肾癌的药物。 选自Galectin-1，Galectin-3和α-烯醇化酶的肾癌的血液标志物。 Galectin-1和/或Galectin-3作为肾癌的血液标志物，用于在诊断成像之前进行的检查。 α-烯醇化酶作为用于肾癌治疗期间和/或之后的监测用于肾癌的血液标志物。